Global Anti-Obesity Drugs Market (2021-2026) by Drug Type, Drug Class, Medication, Distribution Channel, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis
The Global Anti-Obesity Drugs Market is estimated to be USD 3.28 Bn in 2021 and is expected to reach USD 4.64 Bn by 2026, growing at a CAGR of 7.19 %.
Increased consumption of processed and unhealthy foods, lack of physical activity, lack of knowledge about the risk associated with obesity, and rising disposable money are some factors driving the demand for anti-obesity drugs. Furthermost, the rising worry about being overweight or obese is exposing people to a greater risk of developing a variety of chronic illnesses, such as cardiovascular disease, cancer, and diabetes, etc., all of which have high treatment costs, so the public has become more conscious of obesity, which is prompting consumers to turn to anti-obesity medications. In addition, the increasing healthcare spending, favorable reimbursement policies, substantial research and development efforts in the sector, and increased government and non-government organizations' participation in raising awareness and funding research are expected to create more opportunities for the growth of this market.
However, medication side effects, restricted availability of combination therapy, and growing acceptance of other options such as gyms, exercise spas, and other alternatives are likely to restrain and create a challenge for the global anti-obesity drugs market.
The Global Anti-Obesity Drugs Market is segmented further based on Drug Type, Drug Class, Medication, Distribution Channel, and Geography.
By Drug Type, the market is classified as prescription drugs and OTC drugs. Amongst the two, the prescription drugs segment is estimated to hold the highest market share during the forecast period.
By Drug Class, the market is classified as peripherally acting drugs and centrally acting drugs. Amongst the two, the peripherally acting drugs segment is estimated to hold the highest market share during the forecast period.
By Medication, the market is classified as Monotherapies, Polytherapies, and others, others. Amongst all, the monotherapies segment is estimated to hold the highest market share during the forecast period.
By Distribution Channel, the market is classified as hospital pharmacy, retail pharmacy, and online pharmacy. All the hospital pharmacy segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
1. FDA accepts Eisai's supplemental new drug application (SNDA) to update the labeling for anti-obesity agent Belviq. – 25th February 2019.
2. Currax™ Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc. – 27th September 2019.
3. Currax Launches Why Weight: Communicate Initiative to Encourage Conversations about Weight Loss- 25th June 2021
Some of the companies covered in this report are Alizyme, Arena Pharmaceuticals Inc, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Currax Pharmaceuticals LLC, etc.
IGR Competitive Quadrant
The report includes IGR Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
The report offers a comprehensive evaluation of the Global Anti-Obesity Drugs Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
The report also contains the competitive analysis using IGR Positioning Quadrants, Infogence's Proprietary competitive positioning tool.
A complete analysis of the market, including parent industry
Important market dynamics and trends
Historical, current, and projected size of the market based on value and volume
Market shares and strategies of key players
Recommendations to companies for strengthening their foothold in the market
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook